Document:

Notice of Grant

 EXHIBIT 10.1 
 INVITROGEN CORPORATION 
 NOTICE OF GRANT OF PERFORMANCE SHARES 
 (Executive Agreement with Deferral of Settlement Date) 
 Gregory T. Lucier (the “Participant”) has been granted an award (the “Award”) pursuant to the Invitrogen Corporation 2004 Equity Incentive
Plan (the “Plan”) consisting of one or more rights (each such right being hereinafter referred to as a “Performance Share”) to receive in settlement of each such right one
(1) share of Stock of Invitrogen Corporation, as follows: 
 1.    General Terms. 
  

			
	Date of Grant:	  	March 1, 2007
		
	Number of
Performance
Shares:	  	400,000, increased as of any date by the cumulative number of additional whole and/or fractional Performance Shares, if any, credited to this Award through such date in payment of Dividend
Equivalent Rights as described in the Performance Share Award Agreement (“PSA Agreement”).
		
	Performance
Period:	  	March 1, 2007 – February 28, 2010.
		
	Settlement Date:	  	With respect to each Performance Share, the later of (a) the earlier of [i] the date (if any) on which all conditions for vesting under Section 2 hereof have occurred, or [ii] the date
(if any) on which an acceleration event pursuant to Section 4(a) or 4(b) hereof has occurred, or (b) such later date (if any) elected by the Participant for settlement on a Performance Share Election form of the Company in compliance with Section
409A of the Internal Revenue Code and with the consent of the Company.

 2.    Vesting. Each Tranche may only vest once. Except as otherwise provided in section
4 hereof, for each respective Tranche of Performance Shares to vest, all three of the following conditions must be met: 
  

	 	a.	A Trigger Day for the Tranche must occur; 

  

	 	b.	During the period that includes the Trigger Day and the immediately following 19 Trading Days (each, a “Measurement Period”), the arithmetic mean of the
twenty Closing Prices during the Measurement Period must be at or above the Target Price for such Tranche; and 

  

	 	c.	The Participant must be in continuous Service to the Company through February 28, 2010. 

  

	3.	Expiration of Performance Shares. Any Performance Shares that have not vested by February 28, 2010, shall expire. 

  

	4.	Termination of Service 

 a. Partial Acceleration
— Death, Disability, Not-for-Cause Termination, or Termination for Good Reason. If the Participant’s service to the Company terminates as a result of 
  

	 	i.	Death, 

  

	 	ii.	Disability, 

  

	 	iii.	Involuntary termination that is not for Cause, or 

  

	 	iv.	Termination by the Participant for Good Reason 

 then 1) any Performance
Shares granted hereby that at the date of such termination are not vested solely because the termination date is before February 28, 2010, shall accelerate and vest on the termination date; 2) any Performance Shares granted hereby for which a
Measurement Period is then in progress shall vest at the end of the Measurement Period, if the arithmetic mean of the twenty Closing Prices during the Measurement Period is at or above the Target Price for its respective Tranche; and 3) no other
Performance Shares shall vest and all Performance Shares not described in clause (1) or (2) shall immediately lapse. 
 b.
Partial Acceleration — Going Private Transaction. If, when the Company is a solvent, going concern, the Company enters into a transaction as a result of which the Company’s stock is no longer traded on a public stock exchange or
public stock market (a “Transaction”), then: 
  

	 	i.	Any and all Performance Shares granted hereby the Target Price of which is at or below the price paid for the Company’s stock by the purchaser(s) in the Transaction shall
accelerate and vest at Closing; and 

  

	 	ii.	No other Performance Shares shall vest. 

 c. No
Acceleration – Voluntary Termination or Termination for Cause. None of the Performance Shares granted hereby shall vest if, on or before February 28, 2010, there is a: 
  

	 	i.	Voluntary termination of service, or 

  

	 	ii.	Involuntary termination for Cause. 

 5.    Procedural Matters 
 a. Termination for Cause. The Company may not terminate the
Participant’s employment for Cause under clause (ii), (iii), (iv), (v), or (vi) of the definition of Cause 

 
set forth below unless: (a) the Company provides the Participant with written notice of its intent to consider termination of the Participant’s
employment for Cause, including a detailed description of the specific reasons which form the basis for such consideration; (b) within 30 days after the date such notice is provided, the Participant shall have a reasonable opportunity to appear
before the Board of Directors, with or without legal representation, at the Participant’s election, to present arguments and evidence on his own behalf to defend such act or acts, or failure to act, and, if such act or failure to act is
correctable, the Participant shall be given 30 days after such meeting to correct such act or failure to act; and (c) following presentation to the Board of Directors as provided in clause (b) above or the Participant’s failure to
appear before the Board of Directors at a date and time specified in the notice and, following expiration of the 30-day period in which to correct such acts or failures to act that are correctable, the Participant may be terminated for Cause only if
(1) the Board of Directors, by an affirmative vote of a majority of its members (excluding the Participant and any other member of the Board of Directors reasonably believed by the Board of Directors to be involved in the events leading the
Board of Directors to terminate the Participant for Cause), determines that the acts or failures to act of the Participant specified in the notice occurred and remained uncorrected, and the Participant’s employment should accordingly be
terminated for Cause; and (2) the Board of Directors provides the Participant with a written determination setting forth in specific detail the basis of such termination of employment which are consistent with the reasons set forth in the
notice. 
 b. Disability. If the Company determines in good faith that the Disability of the Participant has occurred during the term
of this grant, it may give to the Participant written notice in accordance with Section 18(b) of the Change-in-Control Agreement of its intention to terminate the Participant’s employment. In such event, the Participant’s employment
with the Company shall terminate effective on the 30th day after receipt of such notice by the Participant, provided that, within the 30 days after such receipt, the Participant shall not have returned to full-time performance of the
Participant’s duties. 
  

	6.	Definitions: 

 a. The term
“Cause” means (i) repeated violations by the Participant of the Participant’s material responsibilities and material duties under the Employment Agreement, which are demonstrably willful and deliberate on the
Participant’s part and which are not remedied in a reasonable period of time after receipt of written notice from the Company, (ii) commission of an intentional act of fraud, embezzlement or theft by the Participant in connection with the
Participant’s duties or in the course of the Participant’s employment with the Company or its affiliated companies, (iii) violation of any law, regulation, or rule applicable to the Company’s business or reputation, including,
without limitation securities laws, (iv) causing intentional wrongful damage to property of the Company or its affiliated companies, (v) intentionally and wrongfully disclosing secret processes or confidential information of the Company or
its affiliated companies, (vi) conviction of, or plea of nolo contendere to, a felony, which conviction or plea materially harms the business or reputation of the Company, or (vii) participating, without the Company’s express
written consent, in the management of any business enterprise which engages in substantial and direct competition with the Company or its affiliated 

 
companies, provided that in the case of clauses (i) through (vi), any such act or omission shall have been materially harmful to the Company or its
affiliated companies. For purposes of this definition, no act or failure to act shall be deemed “willful” unless effected by the Participant not in good faith and without a reasonable belief that such action or failure to act was in or not
opposed to the Company’s best interests. 
 b. The term “Change-in-Control Agreement” shall mean the
Change-in-Control Agreement between the Participant and the Company effective on March 1, 2007. 
 c. The term “Change in
Control” shall mean 
 i. Any acquisition or series of acquisitions, other than from the Company, by any individual, entity or
group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) of beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of 50% or more of
either the then outstanding shares of common stock of the Company (the “Outstanding Company Common Stock”) or the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of
directors (the “Outstanding Company Voting Securities”), provided, however, that (A) any acquisition by the Company, or any of its subsidiaries, (B) any acquisition by any employee benefit plan (or related trust) sponsored
or maintained by the Company or any of its subsidiaries, or (C) any acquisition or series of acquisitions which results in any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) acquiring
beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of more than 50% of the Outstanding Company Common Stock and while such a beneficial owner such individual, entity or group does not exercise the voting power of his, her
or its Outstanding Company Common Stock or otherwise exercise control with respect to any matter concerning or affecting the Company and promptly sells, transfers, assigns or otherwise disposes of that number of shares of Outstanding Company Common
Stock necessary to reduce his, her or its beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of the Outstanding Company Common Stock to below 50%, as the case may be, shall not constitute a Change in Control; or

 ii. Individuals who as of April 27, 2001, constitute the Board of Directors of the Company (the “Incumbent Board”) cease
for any reason to constitute at least a majority of the Board of Directors of the Company, provided that any individual becoming a director subsequent to April 27, 2001, whose election, or nomination for election, by the Company’s
stockholders was approved by a vote of at least a majority of the directors then comprising the Incumbent Board, shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual
whose initial assumption of office is in connection with an actual or threatened election contest (as such terms are used in Rule 14a-11 of the Regulation 14A promulgated under the Exchange Act) relating to the election of directors of the Company;
or 
  

 iii. Approval by the stockholders of the Company of a complete liquidation or dissolution of the Company,
or of the sale or other disposition of all or substantially all of the assets of the Company, or of a reorganization, merger or consolidation of the Company, in each case, with respect to which all or substantially all of the individuals and
entities who were the respective beneficial owners of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such reorganization, merger or consolidation do not, following such reorganization, merger or
consolidation beneficially own, directly or indirectly, more than 60% of, respectively, the then outstanding shares of common stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of
directors, as the case may be, of the corporation resulting from such reorganization, merger or consolidation. 
 d. “Closing
Price” means the closing price on a specific day of the Company’s common stock as traded on the Market. 
 e.
“Company” means Invitrogen Corporation and any successor to its business and/or assets that assumes and agrees to perform the PSA Agreement by operation of law, or otherwise. 
 f. “Disability” means the absence of the Participant from the Participant’s duties with the Company on a full-time basis for
180 consecutive business days as a result of incapacity due to mental or physical illness which is determined to be total and permanent by a physician selected by the Company or its insurers and acceptable to the Participant or the
Participant’s legal representative (such agreement as to acceptability not to be withheld unreasonably). 
 g. “Employment
Agreement” means the employment agreement between the Company and Gregory T. Lucier effective as of May 26, 2003. 
 h.
“Good Reason” means 
 i. a substantial diminution in the Participant’s position, authority, duties or
responsibilities, excluding non-substantial changes in title or office, and excluding any isolated, insubstantial and inadvertent action not taken in bad faith and which is remedied by the Company promptly after receipt of written notice thereof
given by the Participant; 
 ii. any failure by the Company to comply with any of the provisions of Section 4(b) of the Change-in-Control
Agreement (Compensation), other than an isolated, insubstantial and inadvertent failure not occurring in bad faith and which is remedied by the Company promptly after receipt of written notice thereof given by the Participant; 
 iii. the Company requiring the Participant to be based at any office or location other than the location where the Participant was employed immediately
preceding March 1, 2007, or any office or location less than 50 miles from such location or, following a Change in Control requiring the Participant to travel away from his office in the course of discharging responsibilities or duties which is
significantly more frequent (in terms of either 

 
consecutive days or aggregate days in any calendar year) than was required prior to the Change in Control; 
 iv. any purported termination by the Company of the Participant’s employment otherwise than for Cause, upon Participant’s death, or upon
Participant’s Disability; or 
 v. any failure by Company to require any successor (whether direct or indirect, by purchase, merger,
consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to assume expressly and agree to perform the PSA Agreement in the same manner and to the same extent that the Company would be required to perform
it if no such succession had taken place. 
 For the purposes of this Section 5(h), any good faith determination of “Good Reason” made by the
Participant shall be conclusive. 
 i. “Market” means the Nasdaq Global Select Market or, if different, the primary
stock market on which the Company’s common stock is traded. 
 j. “Target Price” means the price listed below, in
the definition of “Tranche,” for each respective Tranche; provided, that appropriate and proportionate adjustments shall be made in the Target Price in the event of any change in the Stock effected without receipt of consideration
by the Company, whether through merger, consolidation, reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock split, split-up, split-off, spin-off, combination of shares, exchange of shares,
or similar change in the capital structure of the Company, or in the event of payment of a dividend or distribution to the stockholders of the Company in a form other than Stock (excepting normal cash dividends) that has a material effect on the
Fair Market Value, as defined in the Plan, of shares of Stock, in order to prevent dilution or enlargement of the Participant’s rights under this grant. For purposes of the foregoing, conversion of any convertible securities of the Company
shall not be treated as “effected without receipt of consideration by the Company.” 
  

	k.	“Trading Day” means any day between the Date of Grant and February 28, 2010, that the Market is open. 

  

	l.	“Tranche” means any one of the following 6 portions into which the grant is divided: 

  

					
	 Tranche
	  	 No. of Performance Shares
	  	 Target Price

	 Tranche 1
	  	20,000	  	$80.00
	 Tranche 2
	  	80,000	  	$85.00
	 Tranche 3
	  	60,000	  	$90.00
	 Tranche 4
	  	60,000	  	$95.00
	 Tranche 5
	  	60,000	  	$100.00
	 Tranche 6
	  	120,000	  	$105.00

  

 m. “Trigger Day” means any Trading Day on which the Closing Price is at or above
the Target Price for the respective Tranche. 
 By their signatures below, the Company and the Participant agree that the Award is governed by this Notice
and by the provisions of the Plan and the PSA Agreement attached to and made a part of this document. The Participant acknowledges receipt of copies of the Plan and PSA Agreement, represents that the Participant has read and is familiar with its
provisions, and hereby accepts the Award subject to all of its terms and conditions. 

									
	INVITROGEN CORPORATION	 		 		 	PARTICIPANT
				
	By:	 	 	 		 	 
		 		 		 		 	Signature
	Its:	 	 	 		 	 
		 		 		 		 	Date
	Address:	 	 1600 Faraday Avenue	 		 		 	 
		 	 Carlsbad, CA 92008	 		 		 	Address
		 		 		 		 	 

 ATTACHMENTS: 2004 Equity Incentive Plan, as amended to the Date of Grant, PSA Agreement and Performance Share
Election form.Performance Share Agreement

 EXHIBIT 10.2 
 INVITROGEN CORPORATION 
 PERFORMANCE SHARE AWARD AGREEMENT 
 Invitrogen Corporation has granted to the individual (the “Participant”) named in the Notice of Grant of
Performance Shares (the “Notice”) to which this Performance Share Award Agreement (the “Agreement”) is attached an award (the
“Award”) of Performance Shares upon the terms and conditions set forth in the Notice and this Agreement. The Award has been granted pursuant to and shall in all respects be subject to the terms and conditions of
the Invitrogen Corporation 2004 Equity Incentive Plan (the “Plan”), as amended to the Date of Grant. By signing the Notice, the Participant: (a) represents that the Participant has read and is familiar with
the terms and conditions of the Notice, the Plan and this Agreement, (b) accepts the Award subject to all of the terms and conditions of the Notice, the Plan and this Agreement, (c) agrees to accept as binding, conclusive and final all
decisions or interpretations of the Board upon any questions arising under the Notice, the Plan or this Agreement, and (d) acknowledges receipt of a copy of the Notice, the Plan and this Agreement. 
 1.    DEFINITIONS AND CONSTRUCTION.  
 1.1 Definitions. Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Notice or the Plan. 
 1.2 Construction. Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation
of any provision of this Agreement. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term “or” is not intended to be exclusive, unless the context
clearly requires otherwise. 
 2.    ADMINISTRATION.  
 All questions of interpretation concerning this Agreement shall be determined by the Board. All determinations by the Board shall be final and binding
upon all persons having an interest in the Award. Any officer of a Participating Company shall have the authority to act on behalf of the Company with respect to any matter, right, obligation, or election which is the responsibility of or which is
allocated to the Company herein, provided the officer has apparent authority with respect to such matter, right, obligation, or election. 
 3.    SETTLEMENT OF THE AWARD.  
 3.1 No Additional Payment Required. The
Participant shall not be required to make any additional monetary payment (other than applicable tax withholding, if any) upon settlement of the Award. Payment of the aggregate purchase price of the shares of Stock for which the Award is being
settled shall be made in the form of past services rendered by the Participant to a Participating Company or for its benefit which the Board, 

 
by resolution, determines to have a value not less than the aggregate purchase price of such shares of Stock. 
 3.2 Issuance of Shares of Stock. Subject to the provisions of Section 3.6 below, the Company shall issue to the Participant, on
a date within thirty (30) days following the Settlement Date (as defined in the Notice), a number of whole shares of Stock equal to the vested Performance Shares (as defined in the Notice) to be delivered on such Settlement Date, rounded down
to the nearest whole number. Such shares of Stock shall not be subject to any restriction on transfer other than any such restriction as may be required pursuant to Section 3.6. On the Settlement Date, the Company shall pay to the Participant
cash in lieu of any fractional share of Stock represented by a fractional Restricted Stock Unit subject to this Award in an amount equal to the Fair Market Value on the Settlement Date of such fractional share of Stock. 
 3.3 Application of Section 409A. Notwithstanding any inconsistent provision of this Agreement, to the extent the Company determines in good
faith that (a) the settlement of Performance Shares pursuant to this Agreement in connection with the Participant’s termination of Service would constitute deferred compensation subject to the rules of Section 409A, and (b) that
the Participant is a “specified employee” under Section 409A, then only to the extent required to avoid the Participant’s incurrence of any additional tax or interest under Section 409A of the Code, such settlement will be
delayed until the date which is six (6) months after the Participant’s “separation from service” within the meaning of Section 409A. The Company and the Participant agree to negotiate in good faith to reform any provisions
of this Agreement to maintain the maximum extent practicable to the original intent of the applicable provisions without violating the provisions of Section 409A of the Code, if the Company deems such reformation necessary or advisable pursuant
to guidance under Section 409A to avoid the incurrence of any such interest and penalties. Such reformation shall not result in a reduction of the aggregate benefits to the Participant under this Agreement. 
 3.4 Tax Withholding. At the time the Award is granted, or at any time thereafter as requested by the Company, the Participant hereby
authorizes withholding from payroll and any other amounts payable to the Participant, and otherwise agrees to make adequate provision for, any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Company,
if any, which arise in connection with the Award or the issuance of shares of Stock in settlement thereof. The Company shall have no obligation to deliver shares of Stock until the tax withholding obligations of the Company have been satisfied by
the Participant. Upon the request of Participant, the Company shall deduct from the shares of Stock issuable to Participant at the settlement of this Award a number of whole shares of Stock having a Fair Market Value, as determined by the Company,
equal to all or any part of the tax withholding obligations of the Company. The Fair Market Value of any shares of Stock withheld or tendered to satisfy any such tax withholding obligations shall not exceed the amount determined by the applicable
minimum statutory withholding rates. 
 3.5 Certificate Registration. The certificate for the shares as to which the
Award is settled shall be registered in the name of the Participant, or, if applicable, in the names of the heirs of the Participant. 
  

 3.6 Restrictions on Grant of the Award and Issuance of Shares. The grant of the
Award and issuance of shares of Stock upon settlement of the Award shall be subject to compliance with all applicable requirements of federal, state or foreign law with respect to such securities. No shares of Stock may be issued hereunder if the
issuance of such shares would constitute a violation of any applicable federal, state or foreign securities laws or other law or regulations or the requirements of any stock exchange or market system upon which the Stock may then be listed. The
inability of the Company to obtain from any regulatory body having jurisdiction the authority, if any, deemed by the Company’s legal counsel to be necessary to the lawful issuance and sale of any shares subject to the Award shall relieve the
Company of any liability in respect of the failure to issue or sell such shares as to which such requisite authority shall not have been obtained. As a condition to the settlement of the Award, the Company may require the Participant to satisfy any
qualifications that may be necessary or appropriate, to evidence compliance with any applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company. 
 3.7 Fractional Shares. The Company shall not be required to issue fractional shares upon the settlement of the Award. 
 4.    DIVIDEND EQUIVALENT RIGHTS.  
 Effective on the record date of cash dividends on the Stock occurring on and after the Date of Grant and before the Settlement Date, the Number of Performance Shares subject to this Award shall be increased by such
additional whole and/or fractional Performance Shares determined by the following formula: 
 X = (A x B) / C 
 where, 
 “X” is the number of whole and/or fractional Performance Shares to be credited with respect to the Award; 
 “A” is the amount of cash dividends paid on one share of Stock; 
 “B” is the number of whole
and fractional Performance Shares subject to this Award as of the cash dividend record date but immediately prior to the application of this Section; and 
 “C” is the Fair Market Value of a share of Stock on the cash dividend payment date. 
 Such additional Performance
Shares shall be subject to the same terms and conditions and shall be settled in the same manner and at the same time as the Performance Shares originally subject to this Award. 
 5.    NONTRANSFERABILITY OF THE AWARD.  
 Prior the Settlement Date, neither this Award nor any Performance Shares subject to this Award shall be subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, or
garnishment by creditors of the Participant or the Participant’s beneficiary, except by will or by the laws of descent and distribution. 

 6.    EFFECT OF TERMINATION OF SERVICE.  
 If the Participant’s Service with the Company terminates, the Award, if not earlier settled, and to the extent vested as of the date of the
Participant’s termination of Service as provided under the “Termination of Service” in the Grant Notice, shall be settled as provided in Section 3. 
 7.    CHANGE IN CONTROL.  
 In the event of a Change in Control, the
surviving, continuing, successor, or purchasing corporation or other business entity or parent thereof, as the case may be (the “Acquiror”), may, without the consent of the Participant, either assume the
Company’s rights and obligations under the Award or substitute for the Award a substantially equivalent award with respect to the Acquiror’s stock. The failure of the Acquiror to assume or substitute the Award shall constitute “Good
Reason” as defined in the Notice. 
 8.    ADJUSTMENTS FOR CHANGES IN CAPITAL STRUCTURE.  

Subject to any required action by the stockholders of the Company, in the event of any change in the Stock effected without receipt of consideration by
the Company, whether through merger, consolidation, reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock split, split-up, split-off, spin-off, combination of shares, exchange of shares, or
similar change in the capital structure of the Company, or in the event of payment of a dividend or distribution to the stockholders of the Company in a form other than Stock (excepting normal cash dividends) that has a material effect on the Fair
Market Value of shares of Stock, appropriate and proportionate adjustments shall be made in the number and class of shares subject to the Award, and the Target Price, in order to prevent dilution or enlargement of the Participant’s rights under
the Award. For purposes of the foregoing, conversion of any convertible securities of the Company shall not be treated as “effected without receipt of consideration by the Company.” Any fractional share resulting from an adjustment
pursuant to this Section 8 shall be rounded down to the nearest whole number. Such adjustments shall be determined by the Board, and its determination shall be final, binding and conclusive. 
 9.    RIGHTS AS A STOCKHOLDER, DIRECTOR, EMPLOYEE OR CONSULTANT.  
 The Participant shall have no rights as a stockholder with respect to any shares which may be issued in settlement of this Award until the date of the
issuance of a certificate for such shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment shall be made for dividends, distributions or other rights for which
the record date is prior to the date such certificate is issued, except as provided in Section 8 or pursuant to the Dividend Equivalent Rights. If the Participant is an Employee, the Participant understands and acknowledges that, except as
otherwise provided in a separate, written employment agreement between a Participating Company and the Participant, the Participant’s employment is “at will” and is for no specified term. Nothing in this Agreement shall confer upon
the Participant any right to continue in the Service of a Participating Company or interfere in any way with any right of the Participating Company Group to 

 
terminate the Participant’s Service as a Director, an Employee or a Consultant, as the case may be, at any time. 
 10.    LEGENDS.  
 The Company may at any time place legends referencing any applicable federal, state or foreign securities law restrictions on all certificates representing shares of stock issued pursuant to this Agreement. The Participant shall, at the
request of the Company, promptly present to the Company any and all certificates representing shares acquired pursuant to this Award in the possession of the Participant in order to carry out the provisions of this Section. 
 11.    MISCELLANEOUS PROVISIONS.  
 11.1 Further Instruments. The parties hereto agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement. 
 11.2 Binding Effect. Subject to the restrictions on transfer set forth herein, this Agreement shall inure to the benefit of and be binding upon the
parties hereto and their respective heirs, executors, administrators, successors and assigns. 
 11.3 Termination or Amendment. The
Board may terminate or amend the Plan or the Award at any time; provided, however, that except as provided in Section 7 in connection with a Change in Control, no such termination or amendment may adversely affect the Award without the consent
of the Participant unless such termination or amendment is necessary to comply with any applicable law or government regulation. No amendment or addition to this Agreement shall be effective unless in writing. 
 11.4 Notices. Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given (except to the extent that
this Agreement provides for effectiveness only upon actual receipt of such notice) upon personal delivery, upon deposit in the United States Post Office, by registered or certified mail, or with an overnight courier service with postage and fees
prepaid, addressed to the other party at the address shown below that party’s signature or at such other address as such party may designate in writing from time to time to the other party. 
 11.5 Integrated Agreement. The Notice and this Agreement constitute the entire understanding and agreement of the Participant and the Participating
Company Group with respect to the subject matter contained herein or therein and supersedes any prior agreements, understandings, restrictions, representations, or warranties among the Participant and the Participating Company Group with respect to
such subject matter other than those as set forth or provided for herein or therein. To the extent contemplated herein or therein, the provisions of the Notice and the Agreement shall survive any settlement of the Award and shall remain in full
force and effect. 
 11.6 Applicable Law. This Agreement shall be governed by the laws of the State of California as such laws are
applied to agreements between California residents entered into and to be performed entirely within the State of California. 
  

 11.7 Counterparts. The Notice may be executed in counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same instrument.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}]]